Shopping Cart
Remove All
Your shopping cart is currently empty
EPZ020411 is a specific and effective inhibitor of PRMT6 (IC50=10 nM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $137 | 5 days | 5 days | |
| 5 mg | $235 | 7-10 days | 7-10 days | |
| 10 mg | $392 | 7-10 days | 7-10 days |
| Description | EPZ020411 is a specific and effective inhibitor of PRMT6 (IC50=10 nM). |
| Targets&IC50 | PRMT8:0.223 μM, PRMT6:10 nM, PRMT1:0.119 μM |
| In vitro | In PRMT6-overexpressing cells, EPZ020411 does-dependently inhibits H3R2 methylation. |
| In vivo | in vivo: EPZ020411 shows good bioavailability following subcutaneous (SC) dosing in rats making it a suitable tool for in vivo studies. |
| Molecular Weight | 442.6 |
| Formula | C25H38N4O3 |
| Cas No. | 1700663-41-7 |
| Smiles | CNCCN(C)Cc1c[nH]nc1-c1ccc(O[C@H]2C[C@@H](C2)OCCC2CCOCC2)cc1 |
| Relative Density. | 1.16 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 10 mM, Sonication is recommended. | ||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 1 mg/mL (2.26 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.